| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.049 | 0.3 |